105 related articles for article (PubMed ID: 6195482)
1. Cardiovascular activity of SK&F 64139 in the hypertensive rat.
Hieble JP; McCafferty JP; Roesler JM; Pendleton RG; Gessner G; Carey R; Sarau HM; Goldstein M
J Cardiovasc Pharmacol; 1983; 5(5):889-97. PubMed ID: 6195482
[TBL] [Abstract][Full Text] [Related]
2. The influence of SK & F 64139, a phenylethanolamine-N-methyltransferase inhibitor, on centrally mediated cardiovascular effects of alpha-methyldopa and clonidine.
Gerold M; Haeusler G
Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(4):276-81. PubMed ID: 6132343
[TBL] [Abstract][Full Text] [Related]
3. Lowering of blood pressure in hypertensive rats by SKF 64139 and SKF 72223.
Goldstein M; Kinguasa K; Hieble JP; Pendleton RG
Life Sci; 1982 Jun; 30(23):1951-7. PubMed ID: 6125862
[TBL] [Abstract][Full Text] [Related]
4. Acute cardiovascular effects of two central phenylethanolamine-N-methyl-transferase inhibitors in unanesthetized desoxycorticosterone-salt hypertensive rats.
Biollaz B; Biollaz J; Kohlman O; Bresnahan M; Gavras I; Gavras H
Eur J Pharmacol; 1984 Jul; 102(3-4):515-9. PubMed ID: 6489438
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of adrenaline-forming enzyme in the brain prevents one-kidney, one-clip hypertension and deoxycorticosterone acetate-salt hypertension in the rabbit.
Rosendorff C; Melamed JR; Hurwitz ML; Coull A; Jarvis A
Clin Sci (Lond); 1982 Dec; 63(6):573-6. PubMed ID: 7128025
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure response to central and/or peripheral inhibition of phenylethanolamine N-methyltransferase in normotensive and hypertensive rats.
Black J; Waeber B; Bresnahan MR; Gavras I; Gavras H
Circ Res; 1981 Aug; 49(2):518-24. PubMed ID: 7249286
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of phenylethanolamine-N-methyltransferase: effects on brain catecholamine content and blood pressure in DOCA-salt hypertensive rats.
Liang NY; Chandra A; Tessel RE; Grunewald GL; Borchardt RT
Res Commun Chem Pathol Pharmacol; 1984 Dec; 46(3):319-29. PubMed ID: 6515125
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive effects of CGS 19281A, an inhibitor of phenylethanolamine-N-methyltransferase.
Chatelain RE; Manniello MJ; Dardik BN; Rizzo M; Brosnihan KB
J Pharmacol Exp Ther; 1990 Jan; 252(1):117-25. PubMed ID: 2153796
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the antihypertensive activity of SK&F 86466, a selective alpha-2 antagonist, in the rat.
Roesler JM; McCafferty JP; DeMarinis RM; Matthews WD; Hieble JP
J Pharmacol Exp Ther; 1986 Jan; 236(1):1-7. PubMed ID: 2867209
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of SK & F 29661 and 64139 upon adrenal and cardiac catecholamines.
Pendleton RG; Gessner G; Sawyer J
Eur J Pharmacol; 1980 Nov; 68(2):117-27. PubMed ID: 7202481
[TBL] [Abstract][Full Text] [Related]
11. The effects of PNMT inhibitors upon cardiovascular changes induced by hemorrhage in the rat.
Pendleton RG; McCafferty JP; Roesler JM
Eur J Pharmacol; 1980 Aug; 66(1):1-10. PubMed ID: 7408955
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of phenylethanolamine-N-methyltransferase. 2. Comparison of nonaromatic analogs of phenylethanolamines, 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline (SKF-64139) and 2,3-dichloro-alpha-methylbenzylamine: effects on rat brain and adrenal catecholamine content and blood pressure.
Liang NY; Tessel RE; Grunewald GL; Borchardt RT
J Pharmacol Exp Ther; 1982 Nov; 223(2):382-7. PubMed ID: 7131293
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid hypertension and nonadrenal phenylethanolamine N-methyltransferase.
Kennedy B; Elayan H; Ziegler MG
Hypertension; 1993 Apr; 21(4):415-9. PubMed ID: 8458643
[TBL] [Abstract][Full Text] [Related]
14. The blockade of alpha 2-adrenoceptors by the PNMT inhibitaor SK&F 64139.
Goldstein M; Saito M; Lew JY; Hieble JP; Pendleton RG
Eur J Pharmacol; 1980 Oct; 67(2-3):305-8. PubMed ID: 6109637
[TBL] [Abstract][Full Text] [Related]
15. Evidence that alpha-methylepinephrine is an antihypertensive metabolite of alpha-methyldopa.
Goldberg MR; Tung CS; Ring M; Oates JA; Gerkens JF; Robertson D
Clin Exp Hypertens A; 1982; 4(4-5):595-604. PubMed ID: 7105433
[TBL] [Abstract][Full Text] [Related]
16. Pre- and postsynaptic effects of SKF64139, a phenylethanolamine N-methyltransferase inhibitor, in conscious normotensive rats.
Waeber B; Brunner HR; Haeusler G; Gavras H
J Cardiovasc Pharmacol; 1982; 4(5):759-64. PubMed ID: 6182406
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a sodium-induced activation of central neurogenic mechanisms in one-kidney, one-clip renal hypertensive rats.
Waeber B; Gavras H; Gavras I; Chao P; Kohlman O; Bresnahan MR; Brunner HR; Vaughan D
J Pharmacol Exp Ther; 1982 Nov; 223(2):510-5. PubMed ID: 6752375
[TBL] [Abstract][Full Text] [Related]
18. Further characterization of the cardiovascular effects of the dopamine beta-hydroxylase inhibitor SK&F 102698 in conscious hypertensive rats.
Ohlstein EH; Kruse LI; Ezekiel M; Willette RN
J Pharmacol Exp Ther; 1988 Oct; 247(1):186-95. PubMed ID: 3050029
[TBL] [Abstract][Full Text] [Related]
19. Role of vasoconstrictor systems in experimental glucocorticoid-hypertension in rats.
Waeber B; Gavras H; Bresnahan MR; Gavras I; Brunner HR
Clin Sci (Lond); 1983 Sep; 65(3):255-61. PubMed ID: 6872460
[No Abstract] [Full Text] [Related]
20. The effects of an inhibitor of phenylethanolamine N-methyltransferase upon stimulated adrenal catecholamine release and excretion in the rat.
Pendleton RG; Weiner G; Jenkins B; Gessner G
Naunyn Schmiedebergs Arch Pharmacol; 1977 Apr; 297(3):245-50. PubMed ID: 876399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
